Biosimilars: Interchangeable Products May Increase Patient Access Depending on state pharmacy laws, you may substitute an interchangeable biosimilar product at the pharmacy, much like substituting a generic for a brand-name drug. This helps increase patient access to biologics and may reduce patient costs. Learn more about Interchangeable Biological Products from the FDA. Bookmark FDA’s Biosimilars webpage and materials for health care providers and patients. Additional FDA resources you may find helpful: Overview of Biosimilar Products Biosimilar Regulatory Review and Approval (PDF)

 

 

CMS Office of Minority Health  |  Working to Achieve Health Equity Paid for by the US Department of Health and Human Services